InMode Ltd. (NASDAQ:INMD) Shares Sold by Loomis Sayles & Co. L P

Loomis Sayles & Co. L P cut its holdings in InMode Ltd. (NASDAQ:INMD - Free Report) by 9.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 254,420 shares of the healthcare company's stock after selling 27,644 shares during the period. Loomis Sayles & Co. L P owned about 0.37% of InMode worth $4,249,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. River Road Asset Management LLC acquired a new stake in shares of InMode in the 4th quarter valued at about $8,572,000. Seizert Capital Partners LLC lifted its position in InMode by 105.2% in the fourth quarter. Seizert Capital Partners LLC now owns 250,627 shares of the healthcare company's stock valued at $4,185,000 after purchasing an additional 128,483 shares during the period. Systematic Financial Management LP boosted its stake in shares of InMode by 13.3% in the third quarter. Systematic Financial Management LP now owns 982,111 shares of the healthcare company's stock valued at $16,647,000 after buying an additional 115,492 shares in the last quarter. Barclays PLC lifted its holdings in InMode by 113.5% in the third quarter. Barclays PLC now owns 169,630 shares of the healthcare company's stock valued at $2,876,000 after acquiring an additional 90,173 shares during the period. Finally, Hotchkis & Wiley Capital Management LLC lifted its stake in shares of InMode by 12.9% in the third quarter. Hotchkis & Wiley Capital Management LLC now owns 720,750 shares of the healthcare company's stock valued at $12,217,000 after purchasing an additional 82,100 shares during the period. 68.04% of the stock is owned by institutional investors and hedge funds.

InMode Trading Down 10.5 %

Shares of NASDAQ INMD traded down $1.88 during midday trading on Thursday, reaching $16.10. 823,363 shares of the stock were exchanged, compared to its average volume of 1,168,819. InMode Ltd. has a 52-week low of $14.87 and a 52-week high of $20.98. The stock has a 50 day moving average price of $18.38 and a 200-day moving average price of $17.80. The company has a market capitalization of $1.12 billion, a P/E ratio of 6.85 and a beta of 2.08.

Wall Street Analysts Forecast Growth

A number of analysts have commented on INMD shares. Needham & Company LLC reiterated a "hold" rating on shares of InMode in a research report on Tuesday, February 4th. Barclays increased their price target on shares of InMode from $26.00 to $29.00 and gave the company an "overweight" rating in a research report on Wednesday, February 5th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $22.25.

About InMode

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.